Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GRAIL, Inc. - Common Stock (NQ:GRAL)

104.90 -11.16 (-9.62%)
Official Closing Price Updated: 4:15 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GRAIL, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Here's Why This Exciting Healthcare Stock Popped 13% Today ↗
Investors are getting excited by the prospects for Grail's Galleri test in 2026. 
Via The Motley Fool
News headline image
GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth
In a resounding vote of confidence for the future of multi-cancer early detection (MCED), Canaccord Genuity reiterated its "Buy" rating for GRAIL (Nasdaq: GRAL) on Tuesday, January 13, 2026, setting an... 
Via MarketMinute
News headline image
Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025 ↗
Via MarketBeat
News headline image
Earnings Scheduled For November 12, 2025 ↗
 
Via Benzinga
News headline image
Here's Why Grail Soared, Again, in November ↗
A combination of operational improvements and developments at its key rival bolstered the stock recently. 
Via The Motley Fool
News headline image
Why GRAIL Stock Could Be Biotech’s Next Big Breakout ↗
Via MarketBeat
News headline image
Why Grail Stock Zoomed Nearly 7% Higher on Monday ↗
The company has significant potential with its comprehensive cancer test. 
Via The Motley Fool
News headline image
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
GRAIL (GRAL) Q3 2025 Earnings Call Transcript ↗
GRAIL (GRAL) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
GRAIL INC (NASDAQ:GRAL) Q3 2025 Earnings: Tops Revenue and EPS Estimates as Galleri Sales Climb ↗
GRAIL (GRAL) Q3 2025 earnings beat estimates on revenue and EPS, sending the stock higher. Strong growth for its Galleri cancer test drove the positive results. 
Via Chartmill
Topics Earnings
News headline image
Here's Why Grail Stock Exploded Higher by 55% in October ↗
The company demonstrated tangible progress on its path to profitability. 
Via The Motley Fool
News headline image
Grail Stock Is Up 80% Over the Past Month. Here's Why. ↗
This cancer detection test maker just got some great news. 
Via The Motley Fool
News headline image
Grail's CEO Sells 7,200 Shares for nearly $500,000 ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
Topics Artificial Intelligence
News headline image
Why Is GRAL Stock Rising Today? ↗
GRAIL plans to raise about $325 million through a private placement involving both new and existing institutional investors. 
Via Stocktwits
News headline image
Why Grail Stock Soared 14% Higher on Thursday ↗
The company is receiving a significant equity investment as a component of a collaboration agreement with a large business partner. 
Via The Motley Fool
News headline image
Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
This Cancer Detection Pioneer Is Worth a Look ↗
Multicancer detection tests are closing in on FDA approval and potentially major sales. 
Via The Motley Fool
News headline image
GRAIL INC (NASDAQ:GRAL) Reports Mixed Q2 2025 Earnings: Revenue Misses, Loss Narrows ↗
GRAIL Inc. (NASDAQ:GRAL) reported Q2 2025 results with revenue of $35.5M missing estimates, but a narrower EPS loss of -$3.18. Galleri test sales grew 21% YoY. Shares fell 2.6% post-earnings.... 
Via Chartmill
News headline image
Wall Street Rises Ahead Of Fed, Payment Stocks Fall On Stablecoin Bill: What's Driving Markets Wednesday? ↗
U.S. stocks inched higher by midday Wednesday, as traders weighed geopolitical uncertainty and awaited the Federal Reserve's June policy decision. 
Via Benzinga
Topics Economy
News headline image
3 Medical Technology Stocks Outperforming in 2025
Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns. 
Via MarketBeat
News headline image
Earnings Scheduled For August 12, 2025 ↗
 
Via Benzinga
News headline image
Shake Shack, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Market Monitor News May 15 ( eToro, Oklo UP - Grail, American Eagle Outfitters DOWN) ↗
Wall Street pauses after weeks of gains. Nvidia leads tech rally, eToro soars on IPO, and Boeing lands record order amid Trump’s Middle East tour. 
Via Chartmill
Topics Government Initial Public Offering
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Top movers in Tuesday's after hours session ↗
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
News headline image
Earnings Scheduled For May 13, 2025 ↗
 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.